CRCA vs. XTJL
CRCA (ProShares Ultra CRCL) and XTJL (Innovator U.S. Equity Accelerated Plus ETF - July) are both Leveraged Equities funds. Both are actively managed. Their 0.45 correlation means their historical movements had little consistent relationship. CRCA charges 0.95%/yr vs 0.79%/yr for XTJL.
Performance
CRCA vs. XTJL - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, CRCA achieves a -70.23% return, which is significantly lower than XTJL's 6.32% return.
CRCA
- 1D
- -5.20%
- 1M
- -12.09%
- 6M
- -51.11%
- YTD
- -70.23%
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
- ALL TIME*
- —
XTJL
- 1D
- 0.76%
- 1M
- 0.96%
- 6M
- 5.49%
- YTD
- 6.32%
- 1Y
- 14.27%
- 3Y*
- 13.98%
- 5Y*
- 9.55%
- 10Y*
- —
- ALL TIME*
- 9.76%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $13.28M | $18.49M | $44.45M | |
| $26.11K | $26.81K | $267.40K |
CRCA vs. XTJL - Yearly Performance Comparison
| 2026 (YTD) | 2025 | |
|---|---|---|
CRCA ProShares Ultra CRCL | -70.23% | -84.67% |
XTJL Innovator U.S. Equity Accelerated Plus ETF - July | 6.32% | 6.06% |
Correlation
The correlation between CRCA and XTJL is 0.45, which is low. Their historical price movements had little consistent relationship.
| Correlation | |
|---|---|
Correlation (All Time) Calculated using the full available price history since Aug 7, 2025 | 0.45 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CRCA vs. XTJL — Risk / Return Rank
CRCA
Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.
XTJL
CRCA vs. XTJL - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for ProShares Ultra CRCL (CRCA) and Innovator U.S. Equity Accelerated Plus ETF - July (XTJL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| CRCA | XTJL | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | — | — | |
| Sortino ratioReturn per unit of downside risk | — | — | |
| Omega ratioGain probability vs. loss probability | — | 1.36 | — |
| Calmar ratioReturn relative to maximum drawdown | — | 2.55 | — |
| Martin ratioReturn relative to average drawdown | — | 14.07 | — |
Loading charts...
Drawdowns
CRCA vs. XTJL - Drawdown Comparison
The maximum CRCA drawdown since its inception was -95.61%, which is greater than XTJL's maximum drawdown of -23.24%. Use the drawdown chart below to compare losses from any high point for CRCA and XTJL.
Loading charts...
Drawdown Indicators
| CRCA | XTJL | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -95.61% | -23.24% | -72.37% |
Max Drawdown (1Y)Largest decline over 1 year | — | -5.12% | — |
Max Drawdown (3Y)Largest decline over 3 years | — | -16.70% | — |
Max Drawdown (5Y)Largest decline over 5 years | — | -23.24% | — |
Current DrawdownCurrent decline from peak | -95.44% | -0.09% | -95.35% |
Average DrawdownAverage peak-to-trough decline | -74.24% | -3.92% | -70.32% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | — | 0.93% | — |
Volatility
CRCA vs. XTJL - Volatility Comparison
Loading charts...
Volatility by Period
| CRCA | XTJL | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | — | 2.90% | — |
Volatility (6M)Calculated over the trailing 6-month period | — | 6.12% | — |
Volatility (1Y)Calculated over the trailing 1-year period | 193.78% | 7.79% | +185.99% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 193.78% | 15.11% | +178.67% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 193.78% | 15.03% | +178.75% |
CRCA vs. XTJL - Expense Ratio Comparison
CRCA has a 0.95% expense ratio, which is higher than XTJL's 0.79% expense ratio.
Dividends
CRCA vs. XTJL - Dividend Comparison
CRCA's dividend yield for the trailing twelve months is around 7.40%, while XTJL has not paid dividends to shareholders.
| Position | TTM | 2025 |
|---|---|---|
CRCA ProShares Ultra CRCL | 7.40% | 1.06% |
XTJL Innovator U.S. Equity Accelerated Plus ETF - July | 0.00% | 0.00% |
Frequently Asked Questions
CRCA and XTJL have a correlation of 0.45, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, XTJL is cheaper at 0.79% per year. The better choice depends on whether you care most about return, fees, risk, or income.
XTJL is cheaper with a 0.79% expense ratio, compared with 0.95% for CRCA.
CRCA has the higher dividend yield at 7.40%, compared with 0.00% for XTJL.
They also come from different issuers: ProShares and Innovator. Their fees differ too: 0.95% for CRCA and 0.79% for XTJL.
Find the right allocation for CRCA and XTJL
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer